148 related articles for article (PubMed ID: 7848797)
1. The use of bisphosphonates in osteoporosis.
Fleisch H
Br J Clin Pract; 1994; 48(6):323-6. PubMed ID: 7848797
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
Papapoulos SE
Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
[No Abstract] [Full Text] [Related]
3. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology and therapeutic utility of bisphosphonates.
Lourwood DL
Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
Miller PD
Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
[TBL] [Abstract][Full Text] [Related]
6. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 1994 Aug; 20(3):717-34. PubMed ID: 7984786
[TBL] [Abstract][Full Text] [Related]
7. [Diphosphonates--pharmacology and clinical use].
Aaseth J; Syversen U; Førre O
Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
Wüster C; Heilmann P
Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
[TBL] [Abstract][Full Text] [Related]
9. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.
Greenspan SL; Harris ST; Bone H; Miller PD; Orwoll ES; Watts NB; Rosen CJ
Am Fam Physician; 2000 May; 61(9):2731-6. PubMed ID: 10821153
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
12. [The successful development of bisphosphonates in the therapy of osteoporosis].
Fassbender WJ; Stumpf UC; Kurth A
Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance.
Boonen S; Vanderschueren D; Venken K; Milisen K; Delforge M; Haentjens P
J Intern Med; 2008 Oct; 264(4):315-32. PubMed ID: 18823505
[TBL] [Abstract][Full Text] [Related]
14. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
Hodsman A; Adachi J; Olszynski W
CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
Cosman F; Borges JL; Curiel MD
Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
[TBL] [Abstract][Full Text] [Related]
16. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
[No Abstract] [Full Text] [Related]
17. The effects of oestrogen deficiency on the skeleton and its prevention.
Fogelman I
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():5-9. PubMed ID: 8916979
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
19. Risedronate: clinical usage.
Chapurlat RD; Delmas PD
Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal osteoporosis treatment guidelines.
Sambrook P; O'Neill S; Diamond T; Flicker L; MacLennan A
Aust Fam Physician; 2000 Aug; 29(8):751-3, 756-8. PubMed ID: 10958021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
